SOUTH SAN FRANSCISCO, Calif., June 11, 2025 ( GLOBE NEWSWIRE ) -- CERo Therapeutics Holdings, Inc., ( Nasdaq: CERO ) ( "CERo" or the "Company" ) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, today ...

RA'ANANA, Israel, June 11, 2025 ( GLOBE NEWSWIRE ) -- Inspira™ Technologies OXY B.H.N. Ltd.

ROME, June 11, 2025 /PRNewswire/ -- The sense of anticipation is increasing, the names are unveiled, and the stories begin to take shape: today, at the official presentation at the Hall of Honour of the Italian National Olympic Committee, the Fair Play Menarini Foundation announced the names of ...

HOUSTON, June 11, 2025 ( GLOBE NEWSWIRE ) -- Aggreko, a global leader in energy solutions, today announced an expansion of its Greener Upgrades portfolio of products to include the latest in natural gas solutions.

VALLEY FORGE, Pa., June 11, 2025 /PRNewswire/ -- Vanguard today launched Vanguard Multi-Sector Income Bond ETF ( VGMS ) , an actively managed fixed income ETF overseen by Vanguard Fixed Income Group.

MIAMI, June 11, 2025 ( GLOBE NEWSWIRE ) -- Pirucream, the original premium rolled wafer brand with European roots and Latin American flair, will debut its newest snack innovation, Pirucream Bites, at the 2025 Summer Fancy Food Show in New York.

Here's our initial take on Stitch Fix's ( NASDAQ: SFIX ) fiscal third-quarter financial report.Investors initially had trouble deciding what they thought of Stitch Fix's fiscal third-quarter financial report, and it's not surprising once you look at the numbers.

SOMERSET, N.J., June 11, 2025 ( GLOBE NEWSWIRE ) -- CompoSecure, Inc. ( Nasdaq: CMPO ) , a leader in metal payment cards, security, and authentication solutions, today announced that after more than 13 years of service, its Chief Financial Officer, Tim Fitzsimmons will retire once a successor ...

CompoSecure announces that Tim Fitzsimmons, its Chief Financial Officer, will retire from his position once a successor has been named and assumes the role, which is anticipated to occur in the second half of 2025, but no later than January 1, 2026. A comprehensive search will be launched for a ...

Globally recognized Oncology Key Opinion Leader, Brian Andrew Van Tine, MD, PhD, discusses the positive topline results from the U.S. Phase 1B/2 clinical trial evaluating Annamycin for the treatment of Soft Tissue Sarcoma Lung Metastases ...